Camber Capital Takes Big Position in Med-Tech Company Biolase

Camber Capital Management, a hedge fund managed by Stephen Dubois recently disclosed adding a new position to its equity portfolio, BIOLASE Inc (NASDAQ:BIOL).

Keep Reading →